Amy Ayers

424 total citations
25 papers, 114 citations indexed

About

Amy Ayers is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Amy Ayers has authored 25 papers receiving a total of 114 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pathology and Forensic Medicine, 10 papers in Oncology and 7 papers in Genetics. Recurrent topics in Amy Ayers's work include Lymphoma Diagnosis and Treatment (16 papers), Chronic Lymphocytic Leukemia Research (7 papers) and CAR-T cell therapy research (6 papers). Amy Ayers is often cited by papers focused on Lymphoma Diagnosis and Treatment (16 papers), Chronic Lymphocytic Leukemia Research (7 papers) and CAR-T cell therapy research (6 papers). Amy Ayers collaborates with scholars based in United States, Greece and Georgia. Amy Ayers's co-authors include Christopher R. Flowers, Andrew J. Ritter, Jordan Goldstein, Mary Jo Lechowicz, Pamela B. Allen, Sattva S. Neelapu, Esther Kim, Jennifer L. Crombie, Arushi Khurana and Yi Lin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and European Journal of Cancer.

In The Last Decade

Amy Ayers

23 papers receiving 111 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy Ayers United States 7 65 55 28 19 17 25 114
Ai‐Tram N. Bui United States 7 67 1.0× 14 0.3× 38 1.4× 7 0.4× 23 1.4× 15 139
Stephanie K. Fabbro United States 7 25 0.4× 42 0.8× 87 3.1× 26 1.4× 29 1.7× 15 157
Karine Augeul-Meunier France 7 46 0.7× 33 0.6× 15 0.5× 7 0.4× 13 0.8× 13 108
Brian Cox United States 8 91 1.4× 17 0.3× 40 1.4× 24 1.3× 27 1.6× 17 166
Ilias Papadimitriou Greece 9 55 0.8× 36 0.7× 101 3.6× 8 0.4× 53 3.1× 27 207
Andrea Michelerio Italy 6 29 0.4× 32 0.6× 32 1.1× 12 0.6× 44 2.6× 33 107
Divya Koura United States 6 49 0.8× 9 0.2× 7 0.3× 18 0.9× 13 0.8× 18 105
Victoria Nachar United States 8 64 1.0× 27 0.5× 3 0.1× 12 0.6× 6 0.4× 27 138
Délphine Legoupil France 8 90 1.4× 12 0.2× 23 0.8× 10 0.5× 17 1.0× 36 139
Patricia Fairbrother United Kingdom 8 69 1.1× 20 0.4× 34 1.2× 20 1.1× 51 3.0× 27 182

Countries citing papers authored by Amy Ayers

Since Specialization
Citations

This map shows the geographic impact of Amy Ayers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Ayers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Ayers more than expected).

Fields of papers citing papers by Amy Ayers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Ayers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Ayers. The network helps show where Amy Ayers may publish in the future.

Co-authorship network of co-authors of Amy Ayers

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Ayers. A scholar is included among the top collaborators of Amy Ayers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Ayers. Amy Ayers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ahmed, Sairah, Sattva S. Neelapu, Amy Ayers, et al.. (2025). Role of Pulmonary Function Tests to Predict Complications After Chimeric Antigen Receptor T-Cell Therapy. Clinical Lymphoma Myeloma & Leukemia. 25(7). 520–526.
2.
Shouse, Geoffrey, Sara Ahmed, Gilles Salles, et al.. (2025). 671 | GLOFITAMAB FOR THE TREATMENT OF RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA, A REAL‐WORLD EVIDENCE STUDY FROM THE CUBIC CONSORTIUM. Hematological Oncology. 43(S3). 1 indexed citations
3.
Chang, Andrés, Donald J. McGuire, Amy Ayers, et al.. (2025). PD-1 expression identifies proliferating malignant CLL B cells and is a potential biomarker of response to BTK inhibitor therapy. Proceedings of the National Academy of Sciences. 122(36). e2426935122–e2426935122.
4.
Bock, Allison M., Raphael Mwangi, Yucai Wang, et al.. (2024). Defining primary refractory large B-cell lymphoma. Blood Advances. 8(13). 3402–3415. 7 indexed citations
5.
Andersen, Clark R., Amy Ayers, Jason R. Westin, et al.. (2024). Impact of patient demographics and neighborhood socioeconomic variables on clinical trial participation patterns for NHL. Blood Advances. 8(14). 3825–3837. 2 indexed citations
6.
Chang, Andrés, Donald J. McGuire, Amy Ayers, et al.. (2024). PD-1 Expression Identifies Proliferating Chronic Lymphocytic Leukemia Cells and Informs Response and Resistance to BTK Inhibitor Therapy. Blood. 144(Supplement 1). 3235–3235. 1 indexed citations
7.
Valcárcel, Bryan, Amy Ayers, Mansoor Noorani, et al.. (2024). Retreatment with R-CHOP-like Therapy Is Active with Durable Responses in Patients with Late Relapse of Diffuse Large B-Cell Lymphoma. Blood. 144(Supplement 1). 4454–4454. 1 indexed citations
8.
Larson, Melissa C., Carla Casulo, Urshila Durani, et al.. (2023). Patterns of Care and Prognostic Modeling Following Follicular Lymphoma Transformation to Aggressive B-Cell Lymphoma: An Analysis from the LEO Consortium. Blood. 142(Supplement 1). 3111–3111. 1 indexed citations
9.
Bock, Allison M., Raphael Mwangi, Arushi Khurana, et al.. (2023). Defining Primary Refractory Diffuse Large B‐cell Lymphoma (DLBCL) Based on Survival Outcomes. Hematological Oncology. 41(S2). 430–432. 2 indexed citations
10.
Allen, Pamela B., Subir Goyal, Amy Ayers, et al.. (2022). Clinical Presentation and Outcome Differences Between Black Patients and Patients of Other Races and Ethnicities With Mycosis Fungoides and Sézary Syndrome. JAMA Dermatology. 158(11). 1293–1293. 4 indexed citations
11.
12.
Allen, Pamela B., Subir Goyal, Irl Brian Greenwell, et al.. (2021). No Difference in Survival Among Black Patients with Mycosis Fungoides and Sézary Syndrome: A Multicenter Retrospective Analysis. Blood. 138(Supplement 1). 2441–2441. 1 indexed citations
13.
Gouni, Sushanth, Allison Rosenthal, Jennifer L. Crombie, et al.. (2021). A Multi-Center Retrospective Study of Polatuzumab for Patients with Large B-Cell Lymphoma Relapsed after Standard of Care CAR T-Cell Therapy. Blood. 138(Supplement 1). 2495–2495. 1 indexed citations
14.
Williams, Stephanie, Amy Ayers, Michelle A.T. Hildebrandt, Lorna H. McNeill, & Christopher R. Flowers. (2020). Strategies for Overcoming Disparities for Patients With Hematologic Malignanciesand for Improving Enrollment on Clinical Trials. PubMed. 34(3406). 216–223. 2 indexed citations
15.
Ayers, Amy, et al.. (2019). Characterizing Lymphoma Incidence and Disparities for a Cancer Center Catchment Region. Clinical Lymphoma Myeloma & Leukemia. 19(11). 699–708.e5. 6 indexed citations
16.
Rosenthal, Kristen, Amy Ayers, André Goy, et al.. (2019). Clinical impact of Internet-based tools to guide therapeutic decisions for mantle cell lymphoma. Leukemia & lymphoma. 60(9). 2255–2263. 3 indexed citations
17.
Chen, Lillian, et al.. (2019). Priorities for Rural Lymphoma Survivors: A Qualitative Study. Clinical Lymphoma Myeloma & Leukemia. 20(1). 47–52.e3. 13 indexed citations
18.
Piper, Kaitlin N., et al.. (2019). A Qualitative Exploration of Religion, Gender Norms, and Sexual Decision-Making within African American Faith-Based Communities. Sex Roles. 82(3-4). 189–205. 7 indexed citations
19.
Ritter, Andrew J., Jordan Goldstein, Amy Ayers, & Christopher R. Flowers. (2019). Rural and urban patients with diffuse large B-cell and follicular lymphoma experience reduced overall survival: a National Cancer DataBase study. Leukemia & lymphoma. 60(7). 1656–1667. 15 indexed citations
20.
Ayers, Amy. (2010). Personalized Medicine – Future Impact, Pharma Industry Perspective. Journal of Biomolecular Techniques JBT. 21. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ai‐Tram N. Bui Breakdown of academic impact, for papers by Stephanie K. Fabbro Breakdown of academic impact, for papers by Karine Augeul-Meunier Breakdown of academic impact, for papers by Brian Cox Breakdown of academic impact, for papers by Ilias Papadimitriou Breakdown of academic impact, for papers by Andrea Michelerio Breakdown of academic impact, for papers by Divya Koura Breakdown of academic impact, for papers by Victoria Nachar Breakdown of academic impact, for papers by Délphine Legoupil Breakdown of academic impact, for papers by Patricia Fairbrother
Rankless by CCL
2026